Virginia Retirement Systems Et Al Ultragenyx Pharmaceutical Inc. Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 13,769 shares of RARE stock, worth $476,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,769
Previous 19,669
30.0%
Holding current value
$476,407
Previous $715,000
42.1%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding RARE
# of Institutions
362Shares Held
88.2MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$353 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$194 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$136 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$99.9 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$95.9 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.42B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...